This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.
No takes yet. Share an insight, caveat, or question.
Linares-Perdomo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: